| Find a Doctor, Researcher, or Specialist
Search here by name, specialty, or department |
 |
 |
 |
James Feusner, MD
Pediatric Hematology-Oncology, Sickle Cell Disease, Thalassemia
Medical Director, Oncology
Research & PublicationsCLINICAL SPECIALTIES: cancer, tumors, sarcoma, chemotherapy, targeted therapy, brain and spinal cord tumors, pediatric oncology, hepatoblastoma, Wilms tumor blood and bone marrow cancers, blood disorders, anemia, clotting disorders, sickle cell disease, hemophilia, leukemia and lymphoma, Hodgkins and non-Hodgkins, stem cell transplantation
|
|
|
Department Location
Oncology
Main Hospital
747 52nd Street
Oakland, CA 94609
Phone: 510-428-3372
Hematology Oncology
Walnut Creek Campus
2401 Shadelands Drive
Walnut Creek, CA 94598
Phone: (510) 428-3372
Oncology
Reno Clinic
5301 Reno Corporate Dr.
Reno, NV 89511
Phone: 510-428-3372
|
|
Referrals & Immediate Consults
Referring Physicians should phone the specialty department directly and speak with the specialist on call.
Evenings/Weekends: Phone: 510-428-3000 Ask to be connected to the department's specialist on call.
Appointments
Please request a referral from your physician. |
|
|
|
Education & Training
|
Medical School University Washington School of Medicine, WA Residency Children's Orthopedic Hospital & Medical Center, WA |
Board Certification Pediatrics, Pediatrics Hematology/Oncology, American Board of Pediatrics Internship Los Angeles County + University of Southern California Medical Center, CA Fellowship Children's Orthopedic Hospital & Medical Center, WA |
|
Additional Information | Dr. Feusner is an international leader in pediatric oncology including research, supportive care, and education. He was recruited from the University of Washington to direct and build a pediatric oncology center at UCSF Benioff Children's Hospital Oakland (BCHO). In addition, he has served as the Principal Investigator (PI) to the Children’s Cancer Study Group (now the Children’s Oncology Group, COG) for over 30 years and the PI for the local Clinical Community Oncology Program (CCOP) of the East Bay since 1993. He has played a leading role in over 55 national pediatric oncology trial groups. He has been the chair of 11 COG studies. He has led ground breaking work in the treatment of acute promyelocytic leukemia (APML) including the role of trans-retinoic acid and understanding and improving therapy for hepatoblastoma and Wilms’ tumors. Dr. Feusner has a lifelong passion to improve evidence based supportive care for oncology, which has led to major changes in standards of care. He has had many national honors and awards including the recent selection by Vice President Joe Biden as an advisor on the national cancer institute moonshot initiative. He has cared for and assisted in the diagnosis and management of over 1,800 patients. These experiences have led to his strong interest in pediatric oncology transition to adult care and the development of a long-term survivor program. He has received grant support from CCG, COG, NCI, NIH, St. Baldrick’s Foundation and other institutes. He has mentored many of the newer leading pediatric clinical and research oncologists and continues to serve as a one-on-one mentor to hematology oncology fellows. His experience has led him to assume multiple leadership roles including President of the Medical Staff from 2014-2016.
Dr. Feusner has authored or co-authored over 220 manuscripts, books chapters, or abstracts, most of which have been on the topic of pediatric oncology. He has served as a journal reviewer for 27 journals and reviewed over 285 manuscripts, and has server on 12 editorial boards. Dr. Feusner is an integral mentor in the fellowship program, fostering expert clinical care and acumen as well as teaching Quality Improvement methodology in supportive care, leading to numerous publications.
Selected Research and Publications:
- Kutny M, Rajpurkar M, Alonzo T, Feusner J, Gregory J. Identification of risk markers for significant bleeding and thrombosis in pediatric Acute Promyelocytic Leukemia: A report from the Children's Oncology Group Study AAML0631. 2016 (submitted).
- Kutny M, Gregory J, Feusner J. Outcome for Pediatric APL Patients at Children's Oncology Group Sites on the Leukemia Study CALGB 9710. Blood 2016 (submitted).
- Lee P, Rademaker A, Laonzo T, Feusner J, Hijiya N. Obesity is an adverse prognostic factor in adults but not in children and adolescents with acute promyelocytic leukemia. Blood 2016 (submitted).
- Trobaugh-Lotrario A, Feusner J. Unresectable hepatoblastoma: current perspectives. Hepatic Medicine: Evidence and Research 2016 (submitted).
- Rai P, Feusner JH. Cerebral Metastasis of Hepatoblastoma: A Review. J Pediatr Hematol Oncol 2016;38 4:279-82.
- Sung L, Feusner J. Invasive Rothia Infections in Children with Acute Myeloid Leukemia: A report from the Canadian Infections in AML Research Group. Ped Infect Dis J 2016 (submitted).
- Sung L, Dix D, Cellot S, Gillmeister B, Ethier MC, Roslin NM, Johnston DL, Feusner J, Mitchell D, Lewis V, Aplenc R, Yanofsky R, Portwine C, Price V, Zelcer S, Silva M, Bowes L, Michon B, Stobart K, Traubici J, Allen U, Beyene J, den Hollander N, Paterson AD. Single nucleotide polymorphism in IL1B is associated with infection risk in paediatric acute myeloid leukaemia. Clin Microbiol Infect 2016.
- Sung J, Feusner J. Invasive Rothia Infections in children with Acute Myeloid Leukemia: A report from the Canadian Infections in AML Research Group. Ped Hematology Oncology 2016 (accepted).
- Dix D, Aplenc R, Bowes L, Cellot S, Ethier MC, Feusner J, Gillmeister B, Johnston DL, Lewis V, Michon B, Mitchell D, Portwine C, Price V, Silva M, Stobart K, Yanofsky R, Zelcer S, Beyene J, Sung L. Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia. Int J Cancer 2016;138 7:1785-91.
- Coombs CC, DeAngelis LM, Feusner JH, Rowe JM, Tallman MS. Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria. Clin Lymphoma Myeloma Leuk 2016;163:146-51.
- Abla O, Kutny M, Testi A, Feusner J. Management of relapsed and refractory acute promyelocytic leukemia: recommendations from an international expert panel. Blood 2016 (submitted).
- Trobaugh-Lotrario AD, Meyers RL, Feusner JH. Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children's Oncology Group (COG) Phase I and II Studies. J Pediatr Hematol Oncol 2016;38 3:187-90.
- Khurana M, Lee B, Feusner JH. Fever at Diagnosis of Pediatric Acute Lymphoblastic Leukemia: Are Antibiotics Really Necessary? J Pediatr Hematol Oncol 2015;37 7:498-501.
- Trobaugh-Lotrario AD, Meyers RL, Feusner JH. Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children's Oncology Group (COG) Phase I and II Studies. J Pediatr Hematol Oncol 2015.
- Feusner JH, Hastings CA, Agrawal AK, eds. Supportive Care in Pediatric Oncology: A Practical Evidence-Based Approach. Berlin Springer; 2015.
- Zhang L, Samad A, Pombo-de-Oliveria MS, Scelo G, Smith MT, Feusner J, Wiemels JL, Metayer C. Global characteristics of childhood acute promyelocytic leukemia. Blood Reviews 2015;29(2) March 2015:101-25.
- Trobaugh-Lotrario AD, Venkatramani R, Feusner JH. Hepatoblastoma in Children With Beckwith-Wiedemann Syndrome: Does it Warrant Different Treatment? J Pediatr Hematol Oncol 2014.
- Kutny MA, Gregory J, Jr., Feusner JH. Treatment of paediatric APL: how does the therapeutic approach differ from adults? Best Pract Res Clin Haematol 2014;27 1:69-78.
- Karski EE, Dvorak CC, Leung W, Miller W, Shaw PJ, Qayed M, Katsanis E, Feusner JH. Treatment of Hepatoblastoma With High-dose Chemotherapy and Stem Cell Rescue: The Pediatric Blood and Marrow Transplant Consortium Experience and Review of the Literature. J Pediatr Hematol Oncol 2014.
- Dang DN, Morris HD, Feusner JH, Koduru P, Wilson K, Timmons CF, Cavalier M, Luu HS. Therapy-induced Secondary Acute Myeloid Leukemia With t(11;19)(q23;p13.1) in a Pediatric Patient With Relapsed Acute Promyelocytic Leukemia. J Pediatr Hematol Oncol 2014;368:e546-8.
|
|
|
|
|
|
|
|
|
|
|